We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Catheter Ablation Stabilizes Heart Rhythm

By HospiMedica staff writers
Posted on 20 Apr 2006
A procedure for treating cardiac arrhythmia that takes less than two hours to perform offers long-lasting relief and an improved quality of life, a new study shows. More...


Researchers from the University of Michigan Cardiovascular Center (CVC, Ann Arbor, USA) and from San Raffaele Hospital (Milan, Italy) conducted a randomized, controlled trial using long-term automatic daily monitoring of heart rhythm to assess the efficacy of radiofrequency ablation. The study involved 146 patients, 77 of whom were randomized to receive a left atrial catheter ablation procedure known as circumferential pulmonary-vein ablation, while the remaining 69 patients were randomized to a control group.

In all, 74% of study participants who had the procedure were free of their irregular heartbeat a year afterward and did not need rhythm-regulating drugs. They reported a steep drop in the severity of symptoms, and their hearts' left upper chambers returned to normal size. No side effects were reported, although some of the patients needed a second procedure to fully treat their heart rhythm disturbance. The results of the study were published in the March 2, 2006, issue of the New England Journal of Medicine.

We have shown objectively, and with rigorous follow-up, that this procedure is a very good option for patients with symptomatic, chronic atrial fibrillation who otherwise may have to live with atrial fibrillation for the rest of their lives, said lead author Hakan Oral, M.D., an associate professor of medicine at the University of Michigan and a member of the cardiovascular center team that has treated more than 2,000 atrial fibrillation patients using catheter ablation.

Catheter ablation aims to counteract the irregular electrical impulses in the heart muscle by delivering tiny bursts of intense radiofrequency waves to areas of disorganized and rapid electrical activity, generating high heat, and thereby short-circuiting the aberrant electrical impulses. The catheters are inserted through the groin and snaked through the major blood vessels into the heart and into the left atrium, where the ablation takes place.



Related Links:
University of Michigan Cardiovascular Center
San Raffaele Hospital

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Adjustable Mobile Barrier
M-458
IV Therapy Cart
Avalo I.V Therapy Cart
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.